MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B

Hepatology

Volumn 54, Issue 3, 2011, Pages 808-819

  Guo, Hongyan ^a,b   Liu, Haiying ^a,b   Mitchelson, Keith ^a,b,c   Rao, Huiying ^d   Luo, Mingyong ^b,h   Xie, Lan ^a,b   Sun, Yimin ^b,c   Zhang, Liang ^b   Lu, Ying ^a,b   Liu, Ruyu ^d   Ren, Aihui ^b,c   Liu, Shuai ^b,c   Zhou, Shaozhen ^b,c   Zhu, Jiye ^e   Zhou, Yuxiang ^a,b   Huang, Ailong ^f   Wei, Lai ^d   Guo, Yong ^a,b   Cheng, Jing ^a,b,g  

^a Tsinghua University   (China)

^b NATIONAL ENGINEERING RESEARCH CENTER FOR BEIJING BIOCHIP TECHNOLOGY   (China)

^c CapitalBio Corporation   (China)

^d PEKING UNIVERSITY   (China)

^e PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^f CHONGQING MEDICAL UNIVERSITY   (China)

^g TSINGHUA UNIVERSITY   (China)

^h Guangdong Women and Children's Hospital and Health Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1BETA; MICRORNA; MICRORNA 372; MICRORNA 373; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CELL STRAIN HEPG2; CLINICAL ARTICLE; COPY NUMBER VARIATION; ENZYME ASSAY; GENE CLUSTER; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER; PRIORITY JOURNAL; UPREGULATION; VIRUS CELL INTERACTION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; DNA, VIRAL; GENE DOSAGE; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; MICRORNAS; NFI TRANSCRIPTION FACTORS;

EID: 80052026310     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24441     Document Type: Article

References (36)

1. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68.
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
3. Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity 2007; 26: 133-137.
4. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, et al. Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008; 14: 419-427.
5. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008; 47: 1955-1963.
6. Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant BC, Slagle BL, et al. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 2008; 173: 856-864.
7. Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009; 49: 1098-1112.
8. Liu Y, Zhao JJ, Wang CM, Li MY, Han P, Wang L, et al. Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line. Chin Med J (Engl) 2009; 122: 10-14.
9. Li WX, Xie L, He XH, Li JJ, Tu K, Wei L, et al. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 2008; 123: 1616-1622.
10. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001; 98: 5116-5121.
11. Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X, et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26-33.
12. Guo Y, Guo H, Zhang L, Xie H, Zhao X, Wang F, et al. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J Virol 2005; 79: 14392-14403.
13. Pollicino T, Belloni L, Raffa G, Pediconi N, Squadrito G, Raimondo G, et al. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 2006; 130: 823-837.
14. Honigwachs J, Faktor O, Dikstein R, Shaul Y, Laub O. Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer. J Virol 1989; 63: 919-924.
15. Doitsh G, Shaul Y. Enhancer I predominance in hepatitis B virus gene expression. Mol Cell Biol 2004; 24: 1799-1808.
16. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG. miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res 2007; 35: D149-D155.
17. Nagata K, Guggenheimer RA, Hurwitz J. Specific binding of a cellular DNA replication protein to the origin of replication of adenovirus DNA. Proc Natl Acad Sci U S A 1983; 80: 6177-6181.
18. Shaul Y, Ben-Levy R, De-Medina T. High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter. EMBO J 1986; 5: 1967-1971.
19. Plumb M, Fulton R, Breimer L, Stewart M, Willison K, Neil JC. Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines. J Virol 1991; 65: 1991-1999.
20. Apt D, Chong T, Liu YC, Bernard HU. Nuclear Factor-I and Epithelial Cell-Specific Transcription of Human Papillomavirus Type-16. J Virol 1993; 67: 4455-4463.
21. Chaudhry AZ, Vitullo AD, Gronostajski RM. Nuclear factor I-mediated repression of the mouse mammary tumor virus promoter is abrogated by the coactivators p300/CBP and SRC-1. J Biol Chem 1999; 274: 7072-7081.
22. Gronostajski RM. Roles of the NFI/CTF gene family in transcription and development. Gene 2000; 249: 31-45.
23. Kraus RJ, Shadley L, Mertz JE. Nuclear factor 1 family members mediate repression of the BK virus late promoter. Virology 2001; 287: 89-104.
24. Sheeter D, Du P, Rought S, Richman D, Corbeil J. Surface CD4 expression modulated by a cellular factor induced by HIV type 1 infection. AIDS Res Hum Retroviruses 2003; 19: 117-123.
25. Ben-Levy R, Faktor O, Berger I, Shaul Y. Cellular factors that interact with the hepatitis B virus enhancer. Mol Cell Biol 1989; 9: 1804-1809.
26. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-658.
27. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25: 2537-2545.
28. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011; 19: 232-243.
29. Feitelson MA, Lee J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett 2007; 252: 157-170.
30. Pfister S, Remke M, Castoldi M, Bai AH, Muckenthaler MU, Kulozik A, et al. Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes. Acta Neuropathol 2009; 117: 457-464.
31. Li SS, Yu SL, Kao LP, Tsai ZY, Singh S, Chen BZ, et al. Target identification of microRNAs expressed highly in human embryonic stem cells. J Cell Biochem 2009; 106: 1020-1030.
32. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, et al. Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis. Oncogene 2003; 22: 3007-3014.
33. Ori A, Atzmony D, Haviv I, Shaul Y. An NF1 motif plays a central role in hepatitis B virus enhancer. Virology 1994; 204: 600-608.
34. Spandau DF, Lee CH. Repression of the hepatitis B virus enhancer by a cellular factor. J Gen Virol 1992; 73: 131-137.
35. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008; 135: 49-60.
36. Fassati A, Gorlich D, Harrison I, Zaytseva L, Mingot JM. Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J 2003; 22: 3675-3685.